Portfolio

PEPTOMYC SL Announces Treatment of First Patient with its Lead Compound OMO-103 in a Phase I/II Clinical Trial May 6, 2021
FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings March 30, 2021
INBRAIN Neuroelectronics raises over €14M Series A led by Alta Life Sciences, Asabys Partners and CDTI to develop intelligent graphene-based neuroelectronic therapies for brain related disorders March 26, 2021
binx health™ Collaborates with Amazon Business for Delivery of COVID-19 Sample Collection Kits to U.S. Businesses, Schools and Governments March 18, 2021
Green light by the AEMPS to start clinical trials with OMO-103 March 18, 2021

Passeig de Gràcia, 20 2n 3a
08007 Barcelona
+34 682 300 704
alta@altals.com